Zkusit zdarma
Precigen, Inc.

Precigen, Inc.

PGEN
Cena:
$ 4.24
-0.04 (-0.93%)
Valuace
70
Růst
30
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Precigen: Why I Am More Cautious After The Q1 Beat (Downgrade)

Precigen: Why I Am More Cautious After The Q1 Beat (Downgrade)

16:52 21-05-2026

Precigen, Inc. delivered $21.6M in Q1 Papzimeos revenue, aligning with bullish expectations but leav...

Precigen: Full Commercial Validation And Room To Run

Precigen: Full Commercial Validation And Room To Run

9:58 14-05-2026

Precigen is recommended as a buy due to PAPZIMEOS's early FDA approval, its commercial validation, a...

Precigen Q1 Earnings Call Highlights

Precigen Q1 Earnings Call Highlights

0:14 14-05-2026

Precigen NASDAQ: PGEN reported a sharp increase in first-quarter 2026 revenue as the company's first...

Precigen, Inc. (PGEN) Q1 2026 Earnings Call Transcript

Precigen, Inc. (PGEN) Q1 2026 Earnings Call Transcript

22:40 13-05-2026

Precigen, Inc. (PGEN) Q1 2026 Earnings Call Transcript...

Precigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates

Precigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates

18:36 13-05-2026

Precigen, Inc. (PGEN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus E...

Precigen Reports First Quarter 2026 Financial Results and Business Updates

Precigen Reports First Quarter 2026 Financial Results and Business Updates

16:05 13-05-2026

PAPZIMEOS™ launch gaining strong momentum with $21.6 million in net product revenue in the first q...

Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13

Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13

16:05 07-05-2026

GERMANTOWN, Md., May 7, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage bio...

Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million

Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million

7:00 07-04-2026

Plans Underway to Expand Use to Pediatrics, Patient Redosing and European Approval Meg Flippin, Benz...

Precigen, Inc. (PGEN) Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP Transcript

Precigen, Inc. (PGEN) Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP Transcript

1:32 01-04-2026

Precigen, Inc. (PGEN) Discusses Launch and Differentiation of PAPZIMEOS Immunotherapy for Adult RRP ...

Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31

Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31

8:30 30-03-2026

GERMANTOWN, Md., March 30, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage bi...

Precigen (NASDAQ:PGEN) Shares Gap Up on Analyst Upgrade

Precigen (NASDAQ:PGEN) Shares Gap Up on Analyst Upgrade

1:23 27-03-2026

Precigen, Inc. (NASDAQ: PGEN - Get Free Report) gapped up prior to trading on Thursday after Citizen...

Precigen: The Best Potential Blockbuster You've Never Heard Of (Your ENT Has)

Precigen: The Best Potential Blockbuster You've Never Heard Of (Your ENT Has)

13:57 26-03-2026

Precigen maintains a Buy rating as Papzimeos' strong launch and FDA approval signal blockbuster pote...

These Analysts Boost Their Forecasts On Precigen Following Q4 Results

These Analysts Boost Their Forecasts On Precigen Following Q4 Results

12:08 26-03-2026

Precigen, Inc. (NASDAQ: PGEN) reported mixed results for the fourth quarter on Wednesday....

Precigen, Inc. (PGEN) Q4 2025 Earnings Call Transcript

Precigen, Inc. (PGEN) Q4 2025 Earnings Call Transcript

18:56 25-03-2026

Precigen, Inc. (PGEN) Q4 2025 Earnings Call Transcript...

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates

18:37 25-03-2026

Precigen, Inc. (PGEN) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus E...

Precigen Reports Full Year 2025 Financial Results and Business Updates

Precigen Reports Full Year 2025 Financial Results and Business Updates

16:05 25-03-2026

Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS™ (zopapogene...

Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25

Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25

16:05 11-03-2026

GERMANTOWN, Md., March 11, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage ...

Precigen, Inc. (NASDAQ:PGEN) Given Average Rating of “Hold” by Brokerages

Precigen, Inc. (NASDAQ:PGEN) Given Average Rating of “Hold” by Brokerages

4:46 07-03-2026

Shares of Precigen, Inc. (NASDAQ: PGEN - Get Free Report) have been assigned a consensus recommendat...

Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech

Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech

9:34 11-02-2026

Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech...

Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of “Hold” from Brokerages

Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of “Hold” from Brokerages

4:44 10-02-2026

Precigen, Inc. (NASDAQ: PGEN - Get Free Report) has been assigned an average rating of "Hold" from t...

close

NEW EXPERT CONSENSUS PUBLISHED IN THE LARYNGOSCOPE RECOMMENDS PAPZIMEOS (ZOPAPOGENE IMADENOVEC) AS THE NEW STANDARD OF CARE FIRST-LINE TREATMENT FOR ADULTS WITH RECURRENT RESPIRATORY PAPILLOMATOSIS

20-01-2026
INDEPENDENT, EXPERT-LED CONSENSUS PAPER, SPONSORED BY THE RECURRENT RESPIRATORY PAPILLOMATOSIS FOUND...
Více zde

PRECIGEN SHOWCASES RAPID COMMERCIALIZATION MOMENTUM AND GROWING MARKET ADOPTION OF FIRST-AND-ONLY FDA-APPROVED THERAPY FOR RRP AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

12-01-2026
PRECIGEN TRANSITIONED TO A COMMERCIAL STAGE COMPANY WITH THE US APPROVAL OF PAPZIMEOS IN AUGUST 2025...
Více zde

PRECIGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

05-01-2026
GERMANTOWN, MD., JAN. 5, 2026 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICAL COM...
Více zde

PRECIGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND BUSINESS UPDATES

13-11-2025
PAPZIMEOS (ZOPAPOGENE IMADENOVEC-DRBA) RECEIVED FULL APPROVAL BY THE FDA IN AUGUST PAPZIMEOS LAUNCHE...
Více zde

PRECIGEN TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATES ON NOVEMBER 13

06-11-2025
GERMANTOWN, MD. , NOV. 6, 2025 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICAL ...
Více zde

PRECIGEN ANNOUNCES LONG-TERM FOLLOW-UP RESULTS HIGHLIGHTING ONGOING DURABLE COMPLETE RESPONSES AFTER TREATMENT WITH PAPZIMEOS, THE FIRST AND ONLY FDA-APPROVED THERAPY FOR ADULTS WITH RECURRENT RESPIRATORY PAPILLOMATOSIS

13-10-2025
15 OUT OF 18 COMPLETE RESPONDERS (83%) DEMONSTRATE CONTINUED COMPLETE RESPONSE WITH MEDIAN FOLLOW-UP...
Více zde

PRECIGEN ANNOUNCES UP TO $125 MILLION NON-DILUTIVE FINANCING

03-09-2025
$100 MILLION FUNDED AT CLOSE FORTIFIES BALANCE SHEET AND SUPPORTS ROBUST US COMMERCIALIZATION OF PAP...
Více zde

PRECIGEN TO PARTICIPATE IN UPCOMING VIRTUAL FIRESIDE CHATS HOSTED BY CANTOR AND H.C. WAINWRIGHT

25-08-2025
GERMANTOWN, MD. , AUG. 25, 2025 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICAL...
Více zde

PRECIGEN ANNOUNCES FULL FDA APPROVAL OF PAPZIMEOS (ZOPAPOGENE IMADENOVEC-DRBA), THE FIRST AND ONLY APPROVED THERAPY FOR THE TREATMENT OF ADULTS WITH RECURRENT RESPIRATORY PAPILLOMATOSIS

15-08-2025
PAPZIMEOS APPROVAL MARKS A HISTORIC MILESTONE FOR THE RRP PATIENT COMMUNITY AS THE FIRST AND ONLY FD...
Více zde

PRECIGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS UPDATES

14-05-2025
PRGN-2012 HAS THE POTENTIAL TO BE THE FIRST- AND BEST-IN-CLASS TREATMENT FOR RRP COMPANY'S BLA FOR ...
Více zde

PRECIGEN AND RECURRENT RESPIRATORY PAPILLOMATOSIS FOUNDATION TO HOST THE 2025 INTERNATIONAL RRP AWARENESS DAY ON JUNE 11TH

16-04-2025
– INTERNATIONAL EVENT WILL RAISE AWARENESS AND BRING TOGETHER RRP PATIENTS , CAREGIVERS, AND THE H...
Více zde

PRECIGEN REPORTS FULL YEAR 2024 FINANCIAL RESULTS AND BUSINESS UPDATES

19-03-2025
FDA GRANTED PRIORITY REVIEW TO COMPANY'S BLA FOR PRGN-2012 FOR THE TREATMENT OF ADULTS WITH RECURREN...
Více zde

PRECIGEN TO ANNOUNCE FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATES ON MARCH 19TH

13-03-2025
GERMANTOWN, MD. , MARCH 13, 2025 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICA...
Více zde

FDA GRANTS PRIORITY REVIEW TO PRECIGEN'S BLA FOR PRGN-2012 FOR THE TREATMENT OF ADULTS WITH RECURRENT RESPIRATORY PAPILLOMATOSIS WITH PDUFA TARGET ACTION DATE SET FOR AUGUST 27, 2025

25-02-2025
– PRIORITY REVIEW REDUCES THE BLA REVIEW TIMELINE TO 6-MONTHS AND IS GRANTED TO THERAPIES THAT, IF...
Více zde

PRECIGEN TO PRESENT PLANS FOR REALIZING COMMERCIAL VISION FOR PRGN-2012 AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

13-01-2025
–   PRGN-2012 HAS POTENTIAL TO BE FIRST FDA-APPROVED THERAPEUTIC FOR TREATMENT OF RRP, A RARE AN...
Více zde

PRECIGEN TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

09-01-2025
GERMANTOWN, MD. , JAN. 9, 2025 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICAL C...
Více zde

PRECIGEN COMPLETES SUBMISSION OF BLA WITH REQUEST FOR PRIORITY REVIEW TO THE FDA FOR PRGN-2012 FOR THE TREATMENT OF ADULTS WITH RECURRENT RESPIRATORY PAPILLOMATOSIS

30-12-2024
–   PRGN-2012 HAS THE POTENTIAL TO BE THE FIRST FDA-APPROVED THERAPEUTIC FOR THE TREATMENT OF AD...
Více zde

PRECIGEN ANNOUNCES $79.0 MILLION PRIVATE PLACEMENT OFFERING OF CONVERTIBLE PREFERRED STOCK

27-12-2024
GERMANTOWN, MD. , DEC. 27, 2024 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICAL C...
Více zde

PRECIGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND BUSINESS UPDATES

14-11-2024
–   COMPLETED PRE-BLA MEETING WITH FDA WITH FULL ALIGNMENT ON CONTENT OF BLA, INCLUDING CMC MODU...
Více zde

PRECIGEN TO PARTICIPATE IN THE STIFEL 2024 HEALTHCARE CONFERENCE

12-11-2024
GERMANTOWN, MD. , NOV. 12, 2024 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICAL...
Více zde

PRECIGEN TO PARTICIPATE IN THE 2024 CANTOR GLOBAL HEALTHCARE CONFERENCE

16-09-2024
GERMANTOWN, MD. , SEPT. 16, 2024 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICAL ...
Více zde

PRECIGEN REPORTS SECOND QUARTER AND FIRST HALF 2024 FINANCIAL RESULTS AND BUSINESS UPDATES

14-08-2024
– IN JUNE 2024, THE COMPANY ANNOUNCED GROUNDBREAKING PIVOTAL STUDY DATA FOR PRGN-2012 GENE THERAPY...
Více zde

PRECIGEN TO ANNOUNCE SECOND QUARTER AND FIRST HALF 2024 FINANCIAL RESULTS ON AUGUST 14TH

09-08-2024
GERMANTOWN, MD. , AUG. 9, 2024 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICAL C...
Více zde

PRECIGEN ANNOUNCES PRICING OF $30.0 MILLION PUBLIC OFFERING OF COMMON STOCK

07-08-2024
GERMANTOWN, MD. , AUG. 7, 2024 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN) TODAY ANNOUNCED THE PR...
Více zde

PRECIGEN ANNOUNCES PROPOSED $30 MILLION PUBLIC OFFERING OF COMMON STOCK

06-08-2024
GERMANTOWN, MD. , AUG. 6, 2024 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN) TODAY ANNOUNCED IT HAS...
Více zde

PRECIGEN STRATEGICALLY PRIORITIZES PORTFOLIO TO FOCUS ON FIRST POTENTIAL GENE THERAPY LAUNCH

06-08-2024
– PRGN-2012 IS ON TRACK FOR A ROLLING BLA SUBMISSION UNDER AN ACCELERATED APPROVAL PATHWAY; PATIEN...
Více zde

PRECIGEN APPOINTS PHIL TENNANT AS CHIEF COMMERCIAL OFFICER TO SPEARHEAD FIRST POTENTIAL GENE THERAPY LAUNCH

23-07-2024
–  COMPANY STRENGTHENS FOCUS ON BUILDING AND OPTIMIZING COMMERCIAL READINESS AND PRE-LAUNCH ACTIV...
Více zde

PRECIGEN ANNOUNCES GROUNDBREAKING PIVOTAL STUDY DATA FOR PRGN-2012 IN PATIENTS WITH RECURRENT RESPIRATORY PAPILLOMATOSIS IN WHICH MORE THAN HALF OF PATIENTS ACHIEVED COMPLETE RESPONSE

03-06-2024
–   PHASE 1/2 PIVOTAL STUDY MET THE PRIMARY SAFETY AND EFFICACY ENDPOINTS – –   51% (18 OU...
Více zde

PRECIGEN TO HOST A WEBCAST ON JUNE 3RD TO DETAIL PIVOTAL STUDY RESULTS OF PRGN-2012 IN RECURRENT RESPIRATORY PAPILLOMATOSIS PRESENTED AT THE 2024 ASCO ANNUAL MEETING

23-05-2024
GERMANTOWN, MD. , MAY 23, 2024 /PRNEWSWIRE/ -- PRECIGEN, INC. (NASDAQ: PGEN), A BIOPHARMACEUTICAL C...
Více zde

PRECIGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS UPDATES

14-05-2024
–   PIVOTAL PHASE 2 STUDY DATA OF PRGN-2012 FOR THE TREATMENT OF PATIENTS WITH RECURRENT RESPIRA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-11-13 00:00:008-KStáhnout
2025-11-13 00:00:0010-QStáhnout
2025-09-17 01:00:008-KStáhnout
2025-09-17 00:00:008-KStáhnout
2025-09-03 01:00:008-KStáhnout
2025-09-03 00:00:008-KStáhnout
2025-08-18 01:00:008-KStáhnout
2025-08-18 00:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-06-30 01:00:008-KStáhnout
2025-06-30 00:00:008-KStáhnout
2025-05-14 01:00:008-KStáhnout
2025-05-14 01:00:0010-QStáhnout
2025-05-14 00:00:008-KStáhnout
2025-05-14 00:00:0010-QStáhnout
2025-03-19 00:00:008-KStáhnout
2025-03-19 00:00:0010-KStáhnout
2025-03-18 23:00:008-KStáhnout
2025-03-18 23:00:0010-KStáhnout
2025-01-16 00:00:008-KStáhnout
2025-01-15 23:00:008-KStáhnout
2024-12-30 00:00:008-KStáhnout
2024-12-29 23:00:008-KStáhnout
2024-12-26 00:00:008-KStáhnout
2024-12-25 23:00:008-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-14 00:00:0010-QStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-13 23:00:0010-QStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-06 23:00:008-KStáhnout
2024-10-10 01:00:008-KStáhnout
2024-10-10 00:00:008-KStáhnout
2024-09-23 01:00:008-KStáhnout
2024-09-23 00:00:008-KStáhnout
2024-08-30 01:00:008-KStáhnout
2024-08-30 00:00:008-KStáhnout
2024-08-14 01:00:008-KStáhnout
2024-08-14 01:00:0010-QStáhnout
2024-08-14 00:00:008-KStáhnout
2024-08-14 00:00:0010-QStáhnout
2024-08-09 01:00:008-KStáhnout
2024-08-09 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 00:00:008-KStáhnout
2024-07-05 01:00:008-KStáhnout
2024-07-05 00:00:008-KStáhnout
2024-05-14 01:00:008-KStáhnout
2024-05-14 01:00:0010-QStáhnout
2024-03-19 00:00:008-KStáhnout
2024-03-19 00:00:0010-KStáhnout
2024-02-08 00:00:008-KStáhnout
2024-02-07 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-10 01:00:008-KStáhnout
2023-05-10 01:00:0010-QStáhnout
2023-05-10 00:00:008-KStáhnout
2023-05-10 00:00:0010-QStáhnout
2023-04-05 01:00:008-KStáhnout
2023-04-05 00:00:008-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-03-06 00:00:008-KStáhnout
2023-03-06 00:00:0010-KStáhnout
2023-03-05 23:00:008-KStáhnout
2023-03-05 23:00:0010-KStáhnout
2023-01-27 00:00:008-KStáhnout
2023-01-26 23:00:008-KStáhnout
2023-01-24 00:00:008-KStáhnout
2023-01-23 23:00:008-KStáhnout
2023-01-12 00:00:008-KStáhnout
2023-01-11 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-09-21 01:00:008-KStáhnout
2022-09-21 00:00:008-KStáhnout
2022-08-22 01:00:008-KStáhnout
2022-08-22 00:00:008-KStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-07-13 01:00:008-KStáhnout
2022-07-13 00:00:008-KStáhnout
2022-07-05 01:00:008-KStáhnout
2022-07-05 00:00:008-KStáhnout
2022-06-14 01:00:008-KStáhnout
2022-06-14 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-03-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2021-11-08 00:00:0010-QStáhnout
2021-11-07 23:00:0010-QStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-03 23:00:008-KStáhnout
2021-10-12 01:00:008-KStáhnout
2021-10-12 00:00:008-KStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-06-15 01:00:008-KStáhnout
2021-06-15 00:00:008-KStáhnout
2021-05-28 01:00:008-KStáhnout
2021-05-28 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 01:00:0010-QStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-10 00:00:0010-QStáhnout
2021-03-30 01:00:008-KStáhnout
2021-03-30 00:00:008-KStáhnout
2021-03-01 00:00:008-KStáhnout
2021-03-01 00:00:0010-KStáhnout
2021-02-28 23:00:008-KStáhnout
2021-02-28 23:00:0010-KStáhnout
2021-01-26 00:00:008-KStáhnout
2021-01-25 23:00:008-KStáhnout
2021-01-13 00:00:008-KStáhnout
2021-01-12 23:00:008-KStáhnout
2020-12-02 00:00:008-KStáhnout
2020-12-01 23:00:008-KStáhnout
2020-11-09 00:00:008-KStáhnout
2020-11-09 00:00:0010-QStáhnout
2020-11-08 23:00:008-KStáhnout
2020-11-08 23:00:0010-QStáhnout
2020-10-09 01:00:008-KStáhnout
2020-10-09 00:00:008-KStáhnout
2020-09-25 01:00:008-KStáhnout
2020-09-25 00:00:008-KStáhnout
2020-08-14 01:00:008-KStáhnout
2020-08-14 00:00:008-KStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:008-KStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-06-19 01:00:008-KStáhnout
2020-06-19 00:00:008-KStáhnout
2020-06-04 01:00:008-KStáhnout
2020-06-04 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-11 01:00:0010-QStáhnout
2020-05-11 00:00:0010-QStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 00:00:008-KStáhnout
2020-03-02 00:00:008-KStáhnout
2020-03-02 00:00:0010-KStáhnout
2020-03-01 23:00:008-KStáhnout
2020-03-01 23:00:0010-KStáhnout
2020-02-06 00:00:008-KStáhnout
2020-02-05 23:00:008-KStáhnout
2020-02-04 00:00:008-KStáhnout
2020-02-03 23:00:008-KStáhnout
2020-01-15 00:00:008-KStáhnout
2020-01-14 23:00:008-KStáhnout
2020-01-07 00:00:008-KStáhnout
2020-01-06 23:00:008-KStáhnout
2020-01-02 00:00:008-KStáhnout
2020-01-01 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-10-31 00:00:008-KStáhnout
2019-10-30 23:00:008-KStáhnout
2019-09-16 01:00:008-KStáhnout
2019-09-16 00:00:008-KStáhnout
2019-08-09 01:00:0010-QStáhnout
2019-08-09 00:00:0010-QStáhnout
2019-08-08 01:00:008-KStáhnout
2019-08-08 00:00:008-KStáhnout
2019-06-12 01:00:008-KStáhnout
2019-06-12 00:00:008-KStáhnout
2019-05-09 01:00:008-KStáhnout
2019-05-09 01:00:0010-QStáhnout
2019-05-09 00:00:008-KStáhnout
2019-05-09 00:00:0010-QStáhnout
2019-04-22 01:00:008-KStáhnout
2019-04-22 00:00:008-KStáhnout
2019-04-12 01:00:008-KStáhnout
2019-04-12 00:00:008-KStáhnout
2019-04-04 01:00:008-KStáhnout
2019-04-04 00:00:008-KStáhnout
2019-03-01 00:00:0010-KStáhnout
2019-02-28 23:00:0010-KStáhnout
2019-02-28 00:00:008-KStáhnout
2019-02-27 23:00:008-KStáhnout
2019-01-07 00:00:008-KStáhnout
2019-01-06 23:00:008-KStáhnout
2018-12-31 00:00:008-KStáhnout
2018-12-30 23:00:008-KStáhnout
2018-12-26 00:00:008-KStáhnout
2018-12-25 23:00:008-KStáhnout
2018-12-20 00:00:008-KStáhnout
2018-12-19 23:00:008-KStáhnout
2018-11-23 00:00:008-KStáhnout
2018-11-22 23:00:008-KStáhnout
2018-11-08 00:00:008-KStáhnout
2018-11-08 00:00:0010-QStáhnout
2018-11-07 23:00:008-KStáhnout
2018-11-07 23:00:0010-QStáhnout
2018-10-12 01:00:008-KStáhnout
2018-10-12 00:00:008-KStáhnout
2018-09-12 01:00:008-KStáhnout
2018-09-12 00:00:008-KStáhnout
2018-08-13 01:00:0010-QStáhnout
2018-08-13 00:00:0010-QStáhnout
2018-08-09 01:00:008-KStáhnout
2018-08-09 00:00:008-KStáhnout
2018-07-03 01:00:008-KStáhnout
2018-07-03 00:00:008-KStáhnout
2018-06-08 01:00:008-KStáhnout
2018-06-08 00:00:008-KStáhnout
2018-05-10 01:00:008-KStáhnout
2018-05-10 01:00:0010-QStáhnout
2018-05-10 00:00:008-KStáhnout
2018-05-10 00:00:0010-QStáhnout
2018-04-05 01:00:008-KStáhnout
2018-04-05 00:00:008-KStáhnout
2018-03-01 00:00:008-KStáhnout
2018-03-01 00:00:0010-KStáhnout
2018-02-28 23:00:008-KStáhnout
2018-02-28 23:00:0010-KStáhnout
2018-01-19 00:00:008-KStáhnout
2018-01-18 23:00:008-KStáhnout
2018-01-10 00:00:008-KStáhnout
2018-01-09 23:00:008-KStáhnout
2018-01-08 00:00:008-KStáhnout
2018-01-07 23:00:008-KStáhnout
2018-01-02 00:00:008-KStáhnout
2018-01-01 23:00:008-KStáhnout
2017-11-30 00:00:008-KStáhnout
2017-11-29 23:00:008-KStáhnout
2017-11-09 00:00:008-KStáhnout
2017-11-09 00:00:0010-QStáhnout
2017-11-08 23:00:008-KStáhnout
2017-11-08 23:00:0010-QStáhnout
2017-10-16 01:00:008-KStáhnout
2017-10-16 00:00:008-KStáhnout
2017-08-09 01:00:008-KStáhnout
2017-08-09 01:00:0010-QStáhnout
2017-08-09 00:00:008-KStáhnout
2017-08-09 00:00:0010-QStáhnout
2017-06-30 01:00:008-KStáhnout
2017-06-30 00:00:008-KStáhnout
2017-06-16 01:00:008-KStáhnout
2017-06-16 00:00:008-KStáhnout
2017-05-10 01:00:008-KStáhnout
2017-05-10 01:00:0010-QStáhnout
2017-05-10 00:00:008-KStáhnout
2017-05-10 00:00:0010-QStáhnout
2017-04-27 01:00:008-KStáhnout
2017-04-27 00:00:008-KStáhnout
2017-03-31 01:00:008-KStáhnout
2017-03-31 00:00:008-KStáhnout
2017-03-10 00:00:008-KStáhnout
2017-03-09 23:00:008-KStáhnout
2017-03-01 00:00:008-KStáhnout
2017-03-01 00:00:0010-KStáhnout
2017-02-28 23:00:008-KStáhnout
2017-02-28 23:00:0010-KStáhnout
2017-01-24 00:00:008-KStáhnout
2017-01-23 23:00:008-KStáhnout
2017-01-11 00:00:008-KStáhnout
2017-01-10 23:00:008-KStáhnout
2016-12-30 00:00:008-KStáhnout
2016-12-29 23:00:008-KStáhnout
2016-11-09 00:00:008-KStáhnout
2016-11-09 00:00:0010-QStáhnout
2016-11-08 23:00:008-KStáhnout
2016-11-08 23:00:0010-QStáhnout
2016-11-03 00:00:008-KStáhnout
2016-11-02 23:00:008-KStáhnout
2016-08-09 01:00:008-KStáhnout
2016-08-09 01:00:0010-QStáhnout
2016-08-09 00:00:008-KStáhnout
2016-08-09 00:00:0010-QStáhnout
2016-08-08 01:00:008-KStáhnout
2016-08-08 00:00:008-KStáhnout
2016-06-30 01:00:008-KStáhnout
2016-06-30 00:00:008-KStáhnout
2016-06-13 01:00:008-KStáhnout
2016-06-13 00:00:008-KStáhnout
2016-06-06 01:00:008-KStáhnout
2016-06-06 00:00:008-KStáhnout
2016-05-17 01:00:008-KStáhnout
2016-05-17 00:00:008-KStáhnout
2016-05-10 01:00:008-KStáhnout
2016-05-10 01:00:0010-QStáhnout
2016-05-10 00:00:008-KStáhnout
2016-05-10 00:00:0010-QStáhnout
2016-05-04 01:00:008-KStáhnout
2016-05-04 00:00:008-KStáhnout
2016-03-21 00:00:008-KStáhnout
2016-03-20 23:00:008-KStáhnout
2016-03-14 00:00:008-KStáhnout
2016-03-13 23:00:008-KStáhnout
2016-02-29 00:00:008-KStáhnout
2016-02-29 00:00:0010-KStáhnout
2016-02-28 23:00:008-KStáhnout
2016-02-28 23:00:0010-KStáhnout
2016-01-13 00:00:008-KStáhnout
2016-01-12 23:00:008-KStáhnout
2015-12-03 00:00:008-KStáhnout
2015-12-02 23:00:008-KStáhnout
2015-11-12 00:00:008-KStáhnout
2015-11-11 23:00:008-KStáhnout
2015-11-09 00:00:008-KStáhnout
2015-11-09 00:00:0010-QStáhnout
2015-11-08 23:00:008-KStáhnout
2015-11-08 23:00:0010-QStáhnout
2015-10-30 00:00:008-KStáhnout
2015-10-29 23:00:008-KStáhnout
2015-09-28 01:00:008-KStáhnout
2015-09-28 00:00:008-KStáhnout
2015-09-08 01:00:008-KStáhnout
2015-09-08 00:00:008-KStáhnout
2015-08-21 01:00:008-KStáhnout
2015-08-21 00:00:008-KStáhnout
2015-08-12 01:00:008-KStáhnout
2015-08-12 00:00:008-KStáhnout
2015-08-10 01:00:008-KStáhnout
2015-08-10 01:00:0010-QStáhnout
2015-08-10 00:00:008-KStáhnout
2015-08-10 00:00:0010-QStáhnout
2015-07-21 01:00:008-KStáhnout
2015-07-21 00:00:008-KStáhnout
2015-06-18 01:00:008-KStáhnout
2015-06-18 00:00:008-KStáhnout
2015-06-17 01:00:008-KStáhnout
2015-06-17 00:00:008-KStáhnout
2015-06-05 01:00:008-KStáhnout
2015-06-05 00:00:008-KStáhnout
2015-05-12 01:00:008-KStáhnout
2015-05-12 00:00:008-KStáhnout
2015-05-11 01:00:008-KStáhnout
2015-05-11 01:00:0010-QStáhnout
2015-05-11 00:00:008-KStáhnout
2015-05-11 00:00:0010-QStáhnout
2015-04-23 01:00:008-KStáhnout
2015-04-23 00:00:008-KStáhnout
2015-04-07 01:00:008-KStáhnout
2015-04-07 00:00:008-KStáhnout
2015-04-02 01:00:008-KStáhnout
2015-04-02 00:00:008-KStáhnout
2015-04-01 01:00:008-KStáhnout
2015-04-01 00:00:008-KStáhnout
2015-03-30 01:00:008-KStáhnout
2015-03-30 00:00:008-KStáhnout
2015-03-03 00:00:008-KStáhnout
2015-03-02 23:00:008-KStáhnout
2015-03-02 00:00:008-KStáhnout
2015-03-02 00:00:0010-KStáhnout
2015-03-01 23:00:008-KStáhnout
2015-03-01 23:00:0010-KStáhnout
2015-02-19 00:00:008-KStáhnout
2015-02-18 23:00:008-KStáhnout
2015-01-22 00:00:008-KStáhnout
2015-01-21 23:00:008-KStáhnout
2015-01-20 00:00:008-KStáhnout
2015-01-19 23:00:008-KStáhnout
2015-01-14 00:00:008-KStáhnout
2015-01-13 23:00:008-KStáhnout
2014-11-13 00:00:008-KStáhnout
2014-11-13 00:00:0010-QStáhnout
2014-11-12 23:00:008-KStáhnout
2014-11-12 23:00:0010-QStáhnout
2014-09-05 01:00:008-KStáhnout
2014-09-05 00:00:008-KStáhnout
2014-08-14 01:00:008-KStáhnout
2014-08-14 01:00:0010-QStáhnout
2014-08-14 00:00:008-KStáhnout
2014-08-14 00:00:0010-QStáhnout
2014-08-11 01:00:008-KStáhnout
2014-08-11 00:00:008-KStáhnout
2014-07-03 01:00:008-KStáhnout
2014-07-03 00:00:008-KStáhnout
2014-06-13 01:00:008-KStáhnout
2014-06-13 00:00:008-KStáhnout
2014-05-27 01:00:008-KStáhnout
2014-05-27 00:00:008-KStáhnout
2014-05-12 01:00:008-KStáhnout
2014-05-12 00:00:008-KStáhnout
2014-05-09 01:00:0010-QStáhnout
2014-05-09 00:00:0010-QStáhnout
2014-05-07 01:00:008-KStáhnout
2014-05-07 00:00:008-KStáhnout
2014-04-16 01:00:008-KStáhnout
2014-04-16 00:00:008-KStáhnout
2014-03-31 01:00:008-KStáhnout
2014-03-31 01:00:0010-KStáhnout
2014-03-31 00:00:008-KStáhnout
2014-03-31 00:00:0010-KStáhnout
2014-03-27 00:00:008-KStáhnout
2014-03-26 23:00:008-KStáhnout
2014-03-07 00:00:008-KStáhnout
2014-03-06 23:00:008-KStáhnout
2014-02-21 00:00:008-KStáhnout
2014-02-20 23:00:008-KStáhnout
2014-01-30 00:00:008-KStáhnout
2014-01-29 23:00:008-KStáhnout
2014-01-15 00:00:008-KStáhnout
2014-01-14 23:00:008-KStáhnout
2014-01-13 00:00:008-KStáhnout
2014-01-12 23:00:008-KStáhnout
2013-12-23 00:00:008-KStáhnout
2013-12-22 23:00:008-KStáhnout
2013-11-07 00:00:008-KStáhnout
2013-11-07 00:00:0010-QStáhnout
2013-11-06 23:00:008-KStáhnout
2013-10-04 01:00:008-KStáhnout
2013-10-04 00:00:008-KStáhnout
2013-10-01 00:00:008-KStáhnout
2013-09-20 00:00:008-KStáhnout
2013-08-15 00:00:008-KStáhnout
preloader